The European Centre for Disease Prevention and Control (ECDC) has issued a stark warning: antibiotic resistance is escalating across Europe, and in some member states the situation is deteriorating sharply. In its latest epidemiological report, the agency highlights that infections caused by multidrug-resistant bacteria are on the rise, leaving doctors with fewer effective treatment options and threatening the very foundations of modern medicine.
Each year, more than 35,000 people die from antimicrobial resistance (AMR) in the European Union, Iceland, Liechtenstein and Norway — a death toll comparable to the combined mortality of influenza, tuberculosis and HIV. The ECDC's report, released on Wednesday, underscores that without urgent action, routine medical procedures could become perilous.
“Without effective antibiotics, we could return to the ‘pre-antibiotic era’, and it would be difficult, if not impossible, to safely perform organ transplantation, cancer chemotherapy, ensure intensive care or other medical procedures,” the report warns.
Christian Giske, head of the ECDC’s Antimicrobial Resistance and Healthcare-Associated Infections Section, told reporters on Tuesday that the growing resistance is leaving clinicians with fewer options. “We can also see not only that many of the strains are related, suggesting that there is indeed strain transmission, but we can see that they are increasingly getting very difficult to treat because of their mechanisms of resistance,” he said.
Alarming trends in key pathogens
The ECDC has identified bloodstream infections caused by resistant bacteria as a particular concern. The region is falling short of its reduction targets, especially for Klebsiella pneumoniae and Escherichia coli (E. coli), both of which are associated with high patient mortality.
Between 2019 and 2025, the estimated EU incidence of antibiotic-resistant E. coli infections grew by 16.4%, despite a target to achieve a 10% reduction from the 2019 baseline. For K. pneumoniae, the situation is even more striking: the incidence in 2025 stood at 3.75 cases per 100,000 people, a 72% increase compared with the 2019 baseline, against a target of a 5% reduction.
Some countries are experiencing dramatic surges. Cyprus has seen a 716% increase in antibiotic-resistant K. pneumoniae infections, reaching 21.29 cases per 100,000 people last year, and a 276% rise in resistant E. coli bloodstream infections. Romania follows with 18.66 cases per 100,000, and Greece with 16.28 per 100,000.
Hungary recorded a staggering 1,622% increase in resistant K. pneumoniae infections, while Croatia saw a 409% rise and Bulgaria a 356% increase. These figures highlight the uneven but pervasive nature of the threat across the continent.
Two-front strategy: prevention and stewardship
Giske stressed that tackling AMR requires action on two fronts: preventing infections and controlling antimicrobial use. More than 70% of the health burden of AMR in Europe is attributable to healthcare-associated infections involving multidrug-resistant bacteria. The ECDC estimates that half of this burden could be prevented through stronger infection prevention and control measures.
“There are some measures that can be done at the point of care that pertain to hand hygiene and protective equipment, but also to placement of infected patients in single rooms and, additionally, to effective environmental cleaning,” Giske said.
At the healthcare system level, he called for appropriate staffing for infection prevention and control, access to suitable laboratory diagnostics, and improved surveillance of resistant bacteria. “Infection prevention and control is about preventing infections and thus stopping the spread of bacteria, while antimicrobial stewardship is about using antibiotics wisely,” he added.
But the problem is not just about how many antibiotics are used; it also depends on which ones are prescribed and how they are used. The ECDC noted that antibiotics are still being prescribed inappropriately for viral infections such as colds, influenza and COVID-19, where they offer no benefit. This unnecessary exposure puts selective pressure on bacteria, allowing resistant strains to survive and spread.
Approximately 90% of total human antibiotic consumption takes place in outpatient or community settings. Infants and preschool-aged children, for example, are frequently given unnecessary antibiotics for viral coughs, colds and sore throats that could resolve on their own.
Preventing infections outside healthcare facilities is equally important. Giske cited good hand hygiene and vaccination, which can reduce the need for hospitalisation and antibiotic use overall. “There are also things that can be done beyond healthcare facilities and system level, and these are some aspects that pertain specifically to the community setting,” he said.
The ECDC's warning comes as Europe also faces other health-related challenges, including hospitals preparing for potential conflict scenarios. The agency's call for stronger prevention and more responsible antibiotic use is a reminder that the threat of AMR is not a distant future problem, but a present-day crisis that demands coordinated action across the continent.


